nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—CYP2C9—brain cancer	0.652	1	CbGaD
Desloratadine—CYP2D6—Lomustine—brain cancer	0.0813	0.303	CbGbCtD
Desloratadine—CYP1A2—Carmustine—brain cancer	0.0804	0.3	CbGbCtD
Desloratadine—CYP2D6—Hydroxyurea—brain cancer	0.0616	0.23	CbGbCtD
Desloratadine—CYP1A2—Etoposide—brain cancer	0.0238	0.089	CbGbCtD
Desloratadine—ABCB1—Etoposide—brain cancer	0.0209	0.0778	CbGbCtD
Desloratadine—Loratadine—CYP2C9—brain cancer	0.00244	1	CrCbGaD
Desloratadine—Hepatic enzyme increased—Hydroxyurea—brain cancer	0.00125	0.0173	CcSEcCtD
Desloratadine—Extrapyramidal disorder—Temozolomide—brain cancer	0.00122	0.017	CcSEcCtD
Desloratadine—Otitis media—Temozolomide—brain cancer	0.00118	0.0164	CcSEcCtD
Desloratadine—Rash maculo-papular—Hydroxyurea—brain cancer	0.00107	0.0149	CcSEcCtD
Desloratadine—Viral infection—Temozolomide—brain cancer	0.00102	0.0142	CcSEcCtD
Desloratadine—Hepatic enzyme increased—Temozolomide—brain cancer	0.000974	0.0135	CcSEcCtD
Desloratadine—Infection—Carboplatin—brain cancer	0.000973	0.0135	CcSEcCtD
Desloratadine—Infection—Lomustine—brain cancer	0.000851	0.0118	CcSEcCtD
Desloratadine—Anorexia—Lomustine—brain cancer	0.000816	0.0113	CcSEcCtD
Desloratadine—Epistaxis—Procarbazine—brain cancer	0.000804	0.0112	CcSEcCtD
Desloratadine—Body temperature increased—Carboplatin—brain cancer	0.000774	0.0108	CcSEcCtD
Desloratadine—Breast disorder—Hydroxyurea—brain cancer	0.000774	0.0108	CcSEcCtD
Desloratadine—Hallucination—Procarbazine—brain cancer	0.000762	0.0106	CcSEcCtD
Desloratadine—Decreased appetite—Lomustine—brain cancer	0.000745	0.0103	CcSEcCtD
Desloratadine—Body temperature increased—Lomustine—brain cancer	0.000677	0.00941	CcSEcCtD
Desloratadine—Rash maculo-papular—Etoposide—brain cancer	0.00067	0.00931	CcSEcCtD
Desloratadine—Infestation—Hydroxyurea—brain cancer	0.00066	0.00917	CcSEcCtD
Desloratadine—Infestation NOS—Hydroxyurea—brain cancer	0.00066	0.00917	CcSEcCtD
Desloratadine—Affect lability—Temozolomide—brain cancer	0.000658	0.00915	CcSEcCtD
Desloratadine—Mood swings—Temozolomide—brain cancer	0.000634	0.00881	CcSEcCtD
Desloratadine—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000624	0.00867	CcSEcCtD
Desloratadine—Breast disorder—Temozolomide—brain cancer	0.000604	0.0084	CcSEcCtD
Desloratadine—Hallucination—Hydroxyurea—brain cancer	0.000589	0.00819	CcSEcCtD
Desloratadine—Cough—Procarbazine—brain cancer	0.000581	0.00808	CcSEcCtD
Desloratadine—Convulsion—Procarbazine—brain cancer	0.000577	0.00802	CcSEcCtD
Desloratadine—Myalgia—Procarbazine—brain cancer	0.000567	0.00788	CcSEcCtD
Desloratadine—Bronchitis—Temozolomide—brain cancer	0.000556	0.00773	CcSEcCtD
Desloratadine—Dry mouth—Procarbazine—brain cancer	0.000555	0.00771	CcSEcCtD
Desloratadine—Vomiting—Lomustine—brain cancer	0.000545	0.00757	CcSEcCtD
Desloratadine—Oedema—Procarbazine—brain cancer	0.000544	0.00756	CcSEcCtD
Desloratadine—Infection—Procarbazine—brain cancer	0.00054	0.00751	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Temozolomide—brain cancer	0.000537	0.00747	CcSEcCtD
Desloratadine—Tachycardia—Procarbazine—brain cancer	0.000531	0.00738	CcSEcCtD
Desloratadine—Urinary tract infection—Carmustine—brain cancer	0.000518	0.00721	CcSEcCtD
Desloratadine—Anorexia—Procarbazine—brain cancer	0.000518	0.0072	CcSEcCtD
Desloratadine—Erythema—Hydroxyurea—brain cancer	0.000516	0.00717	CcSEcCtD
Desloratadine—Infestation—Temozolomide—brain cancer	0.000515	0.00716	CcSEcCtD
Desloratadine—Infestation NOS—Temozolomide—brain cancer	0.000515	0.00716	CcSEcCtD
Desloratadine—Nausea—Lomustine—brain cancer	0.000509	0.00707	CcSEcCtD
Desloratadine—Urinary tract infection—Temozolomide—brain cancer	0.000501	0.00696	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000495	0.00689	CcSEcCtD
Desloratadine—Insomnia—Procarbazine—brain cancer	0.000492	0.00684	CcSEcCtD
Desloratadine—Hepatobiliary disease—Temozolomide—brain cancer	0.000488	0.00678	CcSEcCtD
Desloratadine—Somnolence—Procarbazine—brain cancer	0.000483	0.00672	CcSEcCtD
Desloratadine—Hallucination—Carmustine—brain cancer	0.000476	0.00662	CcSEcCtD
Desloratadine—Decreased appetite—Procarbazine—brain cancer	0.000473	0.00657	CcSEcCtD
Desloratadine—Connective tissue disorder—Carmustine—brain cancer	0.000471	0.00654	CcSEcCtD
Desloratadine—Fatigue—Procarbazine—brain cancer	0.000469	0.00652	CcSEcCtD
Desloratadine—Hepatitis—Temozolomide—brain cancer	0.000463	0.00643	CcSEcCtD
Desloratadine—Hallucination—Temozolomide—brain cancer	0.00046	0.0064	CcSEcCtD
Desloratadine—Pharyngitis—Temozolomide—brain cancer	0.000459	0.00638	CcSEcCtD
Desloratadine—Connective tissue disorder—Temozolomide—brain cancer	0.000455	0.00632	CcSEcCtD
Desloratadine—Convulsion—Hydroxyurea—brain cancer	0.000447	0.00621	CcSEcCtD
Desloratadine—Gastrointestinal pain—Procarbazine—brain cancer	0.000445	0.00618	CcSEcCtD
Desloratadine—Urticaria—Procarbazine—brain cancer	0.000432	0.006	CcSEcCtD
Desloratadine—Abdominal pain—Procarbazine—brain cancer	0.00043	0.00597	CcSEcCtD
Desloratadine—Body temperature increased—Procarbazine—brain cancer	0.00043	0.00597	CcSEcCtD
Desloratadine—Cardiac disorder—Temozolomide—brain cancer	0.000429	0.00597	CcSEcCtD
Desloratadine—Oedema—Hydroxyurea—brain cancer	0.000421	0.00585	CcSEcCtD
Desloratadine—Mental disorder—Carmustine—brain cancer	0.00042	0.00583	CcSEcCtD
Desloratadine—Infection—Hydroxyurea—brain cancer	0.000418	0.00581	CcSEcCtD
Desloratadine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000418	0.0711	CbGpPWpGaD
Desloratadine—Erythema—Carmustine—brain cancer	0.000417	0.00579	CcSEcCtD
Desloratadine—Nervous system disorder—Hydroxyurea—brain cancer	0.000413	0.00574	CcSEcCtD
Desloratadine—Infestation NOS—Etoposide—brain cancer	0.000412	0.00573	CcSEcCtD
Desloratadine—Infestation—Etoposide—brain cancer	0.000412	0.00573	CcSEcCtD
Desloratadine—Mental disorder—Temozolomide—brain cancer	0.000405	0.00563	CcSEcCtD
Desloratadine—Erythema—Temozolomide—brain cancer	0.000403	0.0056	CcSEcCtD
Desloratadine—Anorexia—Hydroxyurea—brain cancer	0.000401	0.00557	CcSEcCtD
Desloratadine—Hypersensitivity—Procarbazine—brain cancer	0.000401	0.00557	CcSEcCtD
Desloratadine—Asthenia—Procarbazine—brain cancer	0.00039	0.00542	CcSEcCtD
Desloratadine—Hepatobiliary disease—Etoposide—brain cancer	0.00039	0.00542	CcSEcCtD
Desloratadine—Pruritus—Procarbazine—brain cancer	0.000385	0.00535	CcSEcCtD
Desloratadine—Agitation—Carmustine—brain cancer	0.000383	0.00532	CcSEcCtD
Desloratadine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00038	0.0647	CbGpPWpGaD
Desloratadine—Dyspnoea—Hydroxyurea—brain cancer	0.000375	0.00521	CcSEcCtD
Desloratadine—Somnolence—Hydroxyurea—brain cancer	0.000374	0.0052	CcSEcCtD
Desloratadine—Diarrhoea—Procarbazine—brain cancer	0.000372	0.00517	CcSEcCtD
Desloratadine—Dyspepsia—Hydroxyurea—brain cancer	0.00037	0.00515	CcSEcCtD
Desloratadine—Agitation—Temozolomide—brain cancer	0.00037	0.00514	CcSEcCtD
Desloratadine—Angioedema—Temozolomide—brain cancer	0.000368	0.00512	CcSEcCtD
Desloratadine—Decreased appetite—Hydroxyurea—brain cancer	0.000366	0.00508	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000363	0.00505	CcSEcCtD
Desloratadine—Fatigue—Hydroxyurea—brain cancer	0.000363	0.00504	CcSEcCtD
Desloratadine—Convulsion—Carmustine—brain cancer	0.000361	0.00502	CcSEcCtD
Desloratadine—Dizziness—Procarbazine—brain cancer	0.00036	0.005	CcSEcCtD
Desloratadine—Palpitations—Temozolomide—brain cancer	0.000356	0.00495	CcSEcCtD
Desloratadine—Myalgia—Carmustine—brain cancer	0.000355	0.00493	CcSEcCtD
Desloratadine—Cough—Temozolomide—brain cancer	0.000352	0.00489	CcSEcCtD
Desloratadine—Convulsion—Temozolomide—brain cancer	0.000349	0.00485	CcSEcCtD
Desloratadine—Vomiting—Procarbazine—brain cancer	0.000346	0.0048	CcSEcCtD
Desloratadine—Cardiac disorder—Etoposide—brain cancer	0.000344	0.00478	CcSEcCtD
Desloratadine—Myalgia—Temozolomide—brain cancer	0.000343	0.00477	CcSEcCtD
Desloratadine—Rash—Procarbazine—brain cancer	0.000343	0.00476	CcSEcCtD
Desloratadine—Dermatitis—Procarbazine—brain cancer	0.000343	0.00476	CcSEcCtD
Desloratadine—Headache—Procarbazine—brain cancer	0.000341	0.00473	CcSEcCtD
Desloratadine—Oedema—Carmustine—brain cancer	0.00034	0.00473	CcSEcCtD
Desloratadine—Infection—Carmustine—brain cancer	0.000338	0.0047	CcSEcCtD
Desloratadine—Dry mouth—Temozolomide—brain cancer	0.000335	0.00466	CcSEcCtD
Desloratadine—Body temperature increased—Hydroxyurea—brain cancer	0.000333	0.00462	CcSEcCtD
Desloratadine—Tachycardia—Carmustine—brain cancer	0.000332	0.00461	CcSEcCtD
Desloratadine—Anaphylactic shock—Temozolomide—brain cancer	0.000329	0.00457	CcSEcCtD
Desloratadine—Oedema—Temozolomide—brain cancer	0.000329	0.00457	CcSEcCtD
Desloratadine—Infection—Temozolomide—brain cancer	0.000327	0.00454	CcSEcCtD
Desloratadine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000326	0.0554	CbGpPWpGaD
Desloratadine—Anorexia—Carmustine—brain cancer	0.000324	0.00451	CcSEcCtD
Desloratadine—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000324	0.0551	CbGpPWpGaD
Desloratadine—Nausea—Procarbazine—brain cancer	0.000323	0.00449	CcSEcCtD
Desloratadine—Nervous system disorder—Temozolomide—brain cancer	0.000322	0.00448	CcSEcCtD
Desloratadine—Anorexia—Temozolomide—brain cancer	0.000313	0.00436	CcSEcCtD
Desloratadine—Hypersensitivity—Hydroxyurea—brain cancer	0.00031	0.00431	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Carmustine—brain cancer	0.00031	0.00431	CcSEcCtD
Desloratadine—Insomnia—Carmustine—brain cancer	0.000308	0.00428	CcSEcCtD
Desloratadine—Dyspnoea—Carmustine—brain cancer	0.000303	0.00422	CcSEcCtD
Desloratadine—Somnolence—Carmustine—brain cancer	0.000302	0.0042	CcSEcCtD
Desloratadine—Asthenia—Hydroxyurea—brain cancer	0.000302	0.0042	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.0003	0.00416	CcSEcCtD
Desloratadine—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000298	0.0507	CbGpPWpGaD
Desloratadine—Insomnia—Temozolomide—brain cancer	0.000297	0.00413	CcSEcCtD
Desloratadine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000296	0.0504	CbGpPWpGaD
Desloratadine—Decreased appetite—Carmustine—brain cancer	0.000296	0.00411	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Carmustine—brain cancer	0.000294	0.00408	CcSEcCtD
Desloratadine—Dyspnoea—Temozolomide—brain cancer	0.000293	0.00407	CcSEcCtD
Desloratadine—Somnolence—Temozolomide—brain cancer	0.000292	0.00406	CcSEcCtD
Desloratadine—Dyspepsia—Temozolomide—brain cancer	0.000289	0.00402	CcSEcCtD
Desloratadine—Diarrhoea—Hydroxyurea—brain cancer	0.000288	0.004	CcSEcCtD
Desloratadine—Decreased appetite—Temozolomide—brain cancer	0.000286	0.00397	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000284	0.00394	CcSEcCtD
Desloratadine—Fatigue—Temozolomide—brain cancer	0.000283	0.00394	CcSEcCtD
Desloratadine—Cough—Etoposide—brain cancer	0.000281	0.00391	CcSEcCtD
Desloratadine—Convulsion—Etoposide—brain cancer	0.000279	0.00388	CcSEcCtD
Desloratadine—Dizziness—Hydroxyurea—brain cancer	0.000278	0.00387	CcSEcCtD
Desloratadine—Gastrointestinal pain—Carmustine—brain cancer	0.000278	0.00387	CcSEcCtD
Desloratadine—Body temperature increased—Carmustine—brain cancer	0.000269	0.00374	CcSEcCtD
Desloratadine—Abdominal pain—Carmustine—brain cancer	0.000269	0.00374	CcSEcCtD
Desloratadine—Gastrointestinal pain—Temozolomide—brain cancer	0.000269	0.00374	CcSEcCtD
Desloratadine—Vomiting—Hydroxyurea—brain cancer	0.000268	0.00372	CcSEcCtD
Desloratadine—Rash—Hydroxyurea—brain cancer	0.000265	0.00369	CcSEcCtD
Desloratadine—Dermatitis—Hydroxyurea—brain cancer	0.000265	0.00368	CcSEcCtD
Desloratadine—Headache—Hydroxyurea—brain cancer	0.000264	0.00366	CcSEcCtD
Desloratadine—Anaphylactic shock—Etoposide—brain cancer	0.000263	0.00366	CcSEcCtD
Desloratadine—Infection—Etoposide—brain cancer	0.000261	0.00363	CcSEcCtD
Desloratadine—Urticaria—Temozolomide—brain cancer	0.000261	0.00363	CcSEcCtD
Desloratadine—Abdominal pain—Temozolomide—brain cancer	0.00026	0.00361	CcSEcCtD
Desloratadine—Body temperature increased—Temozolomide—brain cancer	0.00026	0.00361	CcSEcCtD
Desloratadine—Tachycardia—Etoposide—brain cancer	0.000257	0.00357	CcSEcCtD
Desloratadine—Anorexia—Etoposide—brain cancer	0.000251	0.00349	CcSEcCtD
Desloratadine—Hypersensitivity—Carmustine—brain cancer	0.000251	0.00348	CcSEcCtD
Desloratadine—Nausea—Hydroxyurea—brain cancer	0.00025	0.00347	CcSEcCtD
Desloratadine—Asthenia—Carmustine—brain cancer	0.000244	0.00339	CcSEcCtD
Desloratadine—Hypersensitivity—Temozolomide—brain cancer	0.000242	0.00337	CcSEcCtD
Desloratadine—Asthenia—Temozolomide—brain cancer	0.000236	0.00328	CcSEcCtD
Desloratadine—Dyspnoea—Etoposide—brain cancer	0.000235	0.00326	CcSEcCtD
Desloratadine—Somnolence—Etoposide—brain cancer	0.000234	0.00325	CcSEcCtD
Desloratadine—Diarrhoea—Carmustine—brain cancer	0.000233	0.00323	CcSEcCtD
Desloratadine—Pruritus—Temozolomide—brain cancer	0.000233	0.00323	CcSEcCtD
Desloratadine—Decreased appetite—Etoposide—brain cancer	0.000229	0.00318	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Etoposide—brain cancer	0.000227	0.00316	CcSEcCtD
Desloratadine—Fatigue—Etoposide—brain cancer	0.000227	0.00315	CcSEcCtD
Desloratadine—Dizziness—Carmustine—brain cancer	0.000225	0.00313	CcSEcCtD
Desloratadine—Diarrhoea—Temozolomide—brain cancer	0.000225	0.00313	CcSEcCtD
Desloratadine—Dizziness—Temozolomide—brain cancer	0.000217	0.00302	CcSEcCtD
Desloratadine—Vomiting—Carmustine—brain cancer	0.000216	0.00301	CcSEcCtD
Desloratadine—Gastrointestinal pain—Etoposide—brain cancer	0.000215	0.00299	CcSEcCtD
Desloratadine—Rash—Carmustine—brain cancer	0.000215	0.00298	CcSEcCtD
Desloratadine—Dermatitis—Carmustine—brain cancer	0.000214	0.00298	CcSEcCtD
Desloratadine—Headache—Carmustine—brain cancer	0.000213	0.00296	CcSEcCtD
Desloratadine—Vomiting—Temozolomide—brain cancer	0.000209	0.00291	CcSEcCtD
Desloratadine—Urticaria—Etoposide—brain cancer	0.000209	0.0029	CcSEcCtD
Desloratadine—Abdominal pain—Etoposide—brain cancer	0.000208	0.00289	CcSEcCtD
Desloratadine—Body temperature increased—Etoposide—brain cancer	0.000208	0.00289	CcSEcCtD
Desloratadine—Rash—Temozolomide—brain cancer	0.000207	0.00288	CcSEcCtD
Desloratadine—Dermatitis—Temozolomide—brain cancer	0.000207	0.00288	CcSEcCtD
Desloratadine—Headache—Temozolomide—brain cancer	0.000206	0.00286	CcSEcCtD
Desloratadine—Nausea—Carmustine—brain cancer	0.000202	0.00281	CcSEcCtD
Desloratadine—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000201	0.0342	CbGpPWpGaD
Desloratadine—Nausea—Temozolomide—brain cancer	0.000195	0.00271	CcSEcCtD
Desloratadine—Hypersensitivity—Etoposide—brain cancer	0.000194	0.00269	CcSEcCtD
Desloratadine—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000193	0.0329	CbGpPWpGaD
Desloratadine—Asthenia—Etoposide—brain cancer	0.000189	0.00262	CcSEcCtD
Desloratadine—Pruritus—Etoposide—brain cancer	0.000186	0.00259	CcSEcCtD
Desloratadine—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000185	0.0314	CbGpPWpGaD
Desloratadine—Diarrhoea—Etoposide—brain cancer	0.00018	0.0025	CcSEcCtD
Desloratadine—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000178	0.0302	CbGpPWpGaD
Desloratadine—Dizziness—Etoposide—brain cancer	0.000174	0.00242	CcSEcCtD
Desloratadine—Vomiting—Etoposide—brain cancer	0.000167	0.00232	CcSEcCtD
Desloratadine—Rash—Etoposide—brain cancer	0.000166	0.00231	CcSEcCtD
Desloratadine—Dermatitis—Etoposide—brain cancer	0.000166	0.0023	CcSEcCtD
Desloratadine—Headache—Etoposide—brain cancer	0.000165	0.00229	CcSEcCtD
Desloratadine—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000156	0.0266	CbGpPWpGaD
Desloratadine—Nausea—Etoposide—brain cancer	0.000156	0.00217	CcSEcCtD
Desloratadine—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.00015	0.0256	CbGpPWpGaD
Desloratadine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000138	0.0235	CbGpPWpGaD
Desloratadine—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000135	0.0229	CbGpPWpGaD
Desloratadine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000128	0.0218	CbGpPWpGaD
Desloratadine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000102	0.0174	CbGpPWpGaD
Desloratadine—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	9.65e-05	0.0164	CbGpPWpGaD
Desloratadine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	8.34e-05	0.0142	CbGpPWpGaD
Desloratadine—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	8.23e-05	0.014	CbGpPWpGaD
Desloratadine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	7.67e-05	0.013	CbGpPWpGaD
Desloratadine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	7.57e-05	0.0129	CbGpPWpGaD
Desloratadine—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	7.52e-05	0.0128	CbGpPWpGaD
Desloratadine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	6.76e-05	0.0115	CbGpPWpGaD
Desloratadine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	6.5e-05	0.0111	CbGpPWpGaD
Desloratadine—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	6.41e-05	0.0109	CbGpPWpGaD
Desloratadine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	6.22e-05	0.0106	CbGpPWpGaD
Desloratadine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	5.27e-05	0.00896	CbGpPWpGaD
Desloratadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	5.24e-05	0.00892	CbGpPWpGaD
Desloratadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	4.67e-05	0.00795	CbGpPWpGaD
Desloratadine—HRH1—IL-4 Signaling Pathway—IRS2—brain cancer	4.22e-05	0.00717	CbGpPWpGaD
Desloratadine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	3.59e-05	0.00611	CbGpPWpGaD
Desloratadine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	3.54e-05	0.00603	CbGpPWpGaD
Desloratadine—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	3.47e-05	0.0059	CbGpPWpGaD
Desloratadine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	3.3e-05	0.00562	CbGpPWpGaD
Desloratadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	3.27e-05	0.00557	CbGpPWpGaD
Desloratadine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	3.26e-05	0.00554	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—PTCH2—brain cancer	2.94e-05	0.00501	CbGpPWpGaD
Desloratadine—HRH1—IL-4 Signaling Pathway—RELA—brain cancer	2.91e-05	0.00495	CbGpPWpGaD
Desloratadine—HRH1—G alpha (q) signalling events—TRPC6—brain cancer	2.9e-05	0.00493	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	2.89e-05	0.00491	CbGpPWpGaD
Desloratadine—CYP1A2—Biological oxidations—CYP2C9—brain cancer	2.8e-05	0.00476	CbGpPWpGaD
Desloratadine—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	2.76e-05	0.00469	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	2.59e-05	0.00441	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—OR4C12—brain cancer	2.58e-05	0.00439	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—OR14C36—brain cancer	2.58e-05	0.00439	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—OR4C12—brain cancer	2.34e-05	0.00399	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—OR14C36—brain cancer	2.34e-05	0.00399	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—PDGFRA—brain cancer	2.23e-05	0.0038	CbGpPWpGaD
Desloratadine—HRH1—IL-4 Signaling Pathway—STAT3—brain cancer	2.2e-05	0.00375	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	1.86e-05	0.00317	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	1.77e-05	0.003	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	1.66e-05	0.00283	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	1.54e-05	0.00263	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—SHH—brain cancer	1.52e-05	0.00258	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PTCH2—brain cancer	1.51e-05	0.00257	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	1.5e-05	0.00255	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	1.49e-05	0.00254	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—PTCH1—brain cancer	1.44e-05	0.00244	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—SMO—brain cancer	1.44e-05	0.00244	CbGpPWpGaD
Desloratadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	1.4e-05	0.00238	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—OR4C12—brain cancer	1.38e-05	0.00235	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—OR14C36—brain cancer	1.38e-05	0.00235	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.38e-05	0.00235	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—ABR—brain cancer	1.3e-05	0.00222	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	1.27e-05	0.00217	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	1.22e-05	0.00208	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IL2—brain cancer	1.22e-05	0.00207	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	1.2e-05	0.00204	CbGpPWpGaD
Desloratadine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	1.2e-05	0.00203	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	1.19e-05	0.00202	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—ABR—brain cancer	1.18e-05	0.00202	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—DTX2—brain cancer	1.18e-05	0.002	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	1.17e-05	0.00199	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	1.15e-05	0.00195	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	1.15e-05	0.00195	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	1.1e-05	0.00188	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.07e-05	0.00183	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	1.05e-05	0.00179	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—VEGFA—brain cancer	1.04e-05	0.00176	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.01e-05	0.00172	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	9.19e-06	0.00156	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	9.08e-06	0.00154	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PTCH2—brain cancer	8.92e-06	0.00152	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HES5—brain cancer	8.64e-06	0.00147	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	8.54e-06	0.00145	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—STRADA—brain cancer	8.38e-06	0.00143	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—TRPC6—brain cancer	8.26e-06	0.00141	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.86e-06	0.00134	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—SHH—brain cancer	7.78e-06	0.00132	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—TRPC6—brain cancer	7.5e-06	0.00128	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—SMO—brain cancer	7.37e-06	0.00125	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PTCH1—brain cancer	7.37e-06	0.00125	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	7.13e-06	0.00121	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ABR—brain cancer	7e-06	0.00119	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GLI2—brain cancer	6.76e-06	0.00115	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	6.64e-06	0.00113	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	6.63e-06	0.00113	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GLI1—brain cancer	6.35e-06	0.00108	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—VAV1—brain cancer	6.19e-06	0.00105	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP2C9—brain cancer	6.14e-06	0.00104	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SUFU—brain cancer	6.02e-06	0.00102	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP2C9—brain cancer	5.99e-06	0.00102	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	5.86e-06	0.000997	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GFAP—brain cancer	5.81e-06	0.000989	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	5.8e-06	0.000988	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP2C9—brain cancer	5.65e-06	0.000961	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—VAV1—brain cancer	5.62e-06	0.000956	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HEY1—brain cancer	5.51e-06	0.000937	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—DLL1—brain cancer	5.4e-06	0.000919	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—BSG—brain cancer	5.22e-06	0.000888	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	5.11e-06	0.000869	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—BSG—brain cancer	5.1e-06	0.000867	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—BSG—brain cancer	4.8e-06	0.000817	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP2C9—brain cancer	4.78e-06	0.000814	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—BSG—brain cancer	4.76e-06	0.00081	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	4.7e-06	0.0008	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	4.6e-06	0.000782	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SHH—brain cancer	4.59e-06	0.000782	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—IDH1—brain cancer	4.49e-06	0.000764	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TRPC6—brain cancer	4.43e-06	0.000754	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—IDH1—brain cancer	4.38e-06	0.000746	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PTCH1—brain cancer	4.36e-06	0.000741	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SMO—brain cancer	4.36e-06	0.000741	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—IDH1—brain cancer	4.13e-06	0.000703	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—IDH1—brain cancer	4.09e-06	0.000697	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—BSG—brain cancer	4.07e-06	0.000692	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CG—brain cancer	3.93e-06	0.000668	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.86e-06	0.000657	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.66e-06	0.000622	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CG—brain cancer	3.57e-06	0.000607	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ENO2—brain cancer	3.55e-06	0.000604	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—IDH1—brain cancer	3.5e-06	0.000595	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NOTCH2—brain cancer	3.48e-06	0.000592	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ENO2—brain cancer	3.46e-06	0.000589	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.33e-06	0.000567	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—VAV1—brain cancer	3.32e-06	0.000565	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ENO2—brain cancer	3.26e-06	0.000555	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ENO2—brain cancer	3.24e-06	0.000551	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HES1—brain cancer	2.85e-06	0.000486	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.85e-06	0.000485	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ENO2—brain cancer	2.77e-06	0.000471	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—IL2—brain cancer	2.76e-06	0.00047	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PDGFRA—brain cancer	2.72e-06	0.000462	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SPP1—brain cancer	2.64e-06	0.000449	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL2—brain cancer	2.51e-06	0.000427	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IRS2—brain cancer	2.39e-06	0.000406	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—APC—brain cancer	2.11e-06	0.000359	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CG—brain cancer	2.11e-06	0.000359	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—EGFR—brain cancer	1.92e-06	0.000327	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—RELA—brain cancer	1.65e-06	0.00028	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ERBB2—brain cancer	1.64e-06	0.000278	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CG—brain cancer	1.63e-06	0.000277	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CG—brain cancer	1.59e-06	0.00027	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CG—brain cancer	1.5e-06	0.000255	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CG—brain cancer	1.48e-06	0.000253	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL2—brain cancer	1.48e-06	0.000252	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCND1—brain cancer	1.45e-06	0.000246	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CTNNB1—brain cancer	1.43e-06	0.000244	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CG—brain cancer	1.27e-06	0.000216	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—VEGFA—brain cancer	1.26e-06	0.000214	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—STAT3—brain cancer	1.25e-06	0.000212	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MYC—brain cancer	1.16e-06	0.000197	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EGFR—brain cancer	1.13e-06	0.000193	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TP53—brain cancer	9.52e-07	0.000162	CbGpPWpGaD
